---
title: "WELLINGTON BIOMEDICAL INNOVATION MASTER INVESTORS (CAYMAN) I L.P. — Ownership Dossier"
canonical: https://whiteintel.dev/entity/48c8939e-22df-5a97-bb4f-a607fc5daf8b
json: https://whiteintel.dev/api/public/dossier/48c8939e-22df-5a97-bb4f-a607fc5daf8b
identifier: sec:0001787092
jurisdiction: US
risk: Low
source: WhiteIntel corporate-ownership graph
---

# WELLINGTON BIOMEDICAL INNOVATION MASTER INVESTORS (CAYMAN) I L.P.

**Type:** Company  
**Jurisdiction:** [US](https://whiteintel.dev/jurisdictions/us)  
**Identifier:** `sec:0001787092`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/48c8939e-22df-5a97-bb4f-a607fc5daf8b  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/48c8939e-22df-5a97-bb4f-a607fc5daf8b  

## Ownership & control

### Holdings / subsidiaries

- **Zenas BioPharma, Inc.** (tenpercentowner) — https://whiteintel.dev/entity/8a62e26a-40ca-50e6-b06d-efea9f8a52da
- **Artiva Biotherapeutics, Inc.** (tenpercentowner) — https://whiteintel.dev/entity/f4e3723b-874a-5417-92c5-396aa264fb42
- **Boundless Bio, Inc.** (tenpercentowner) — https://whiteintel.dev/entity/adcd4b25-680c-5d72-8d95-904e59ace4a0
- **Acrivon Therapeutics, Inc.** (tenpercentowner) — https://whiteintel.dev/entity/374491c8-21b8-5dc7-9616-741799d55196
- **Nuvalent, Inc.** (tenpercentowner) — https://whiteintel.dev/entity/c311f0a0-a099-557a-ba70-bfce08965197
- **Verve Therapeutics, Inc.** (tenpercentowner) — https://whiteintel.dev/entity/fbb9c528-b331-50f5-bf1d-aea89540ca82
- **Edgewise Therapeutics, Inc.** (tenpercentowner) — https://whiteintel.dev/entity/8a5e122d-7278-5f7d-88fd-4cc49f252dff
- **Aligos Therapeutics, Inc.** (tenpercentowner) — https://whiteintel.dev/entity/15206969-c284-5758-b9c6-6d6ff804a67a
- **Olema Pharmaceuticals, Inc.** (tenpercentowner) — https://whiteintel.dev/entity/63f4ec36-6123-58df-98c8-2a1210390729
- **Nurix Therapeutics, Inc.** (tenpercentowner) — https://whiteintel.dev/entity/b60a7183-c5e9-5acd-afd8-e71eb061db09
- **PMV Pharmaceuticals, Inc.** (other) — https://whiteintel.dev/entity/145c0230-20e9-5ce1-9a0c-f0f190c90d7e
- **Dyne Therapeutics, Inc.** (tenpercentowner) — https://whiteintel.dev/entity/6f3d0b50-7aa7-52a8-a2f9-11ef56e96f8c

…and **4** more subsidiaries/holdings. Resolve the full list with `get_dossier` on the WhiteIntel MCP (`npx -y @whiteintel/mcp-server`) or a one-off dossier — https://whiteintel.dev/pricing.

## Get the full, resolved dossier (agent-callable)

The above is the free teaser. The resolved **multi-hop UBO chain**, ownership **%**, full **financial history**, itemised **assets** and the hop-by-hop **exposure path** are the paid depth — callable as tools from your agent:

```bash
npx -y @whiteintel/mcp-server   # then: get_dossier · trace_ownership_path · check_offshore_exposure
```

Or unlock a one-off cited dossier for **WELLINGTON BIOMEDICAL INNOVATION MASTER INVESTORS (CAYMAN) I L.P.** — https://whiteintel.dev/entity/48c8939e-22df-5a97-bb4f-a607fc5daf8b · pricing https://whiteintel.dev/pricing.

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **WELLINGTON BIOMEDICAL INNOVATION MASTER INVESTORS (CAYMAN) I L.P.**. Human view: https://whiteintel.dev/entity/48c8939e-22df-5a97-bb4f-a607fc5daf8b · Structured JSON: https://whiteintel.dev/api/public/dossier/48c8939e-22df-5a97-bb4f-a607fc5daf8b._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._